GB Patent

GB8909793D0 — Pharmaceutical formulation

Assigned to Beecham Group PLC · Expires 1989-06-14 · 37y expired

What this patent protects

A chewable tablet comprises a medicament dispersed in a chewable base, such as mannitol, together with an effervescent couple, such as citric acid - sodium bicarbonate. The combination of effervescence and chewability with optional flavourings improves the taste characteristics o…

USPTO Abstract

A chewable tablet comprises a medicament dispersed in a chewable base, such as mannitol, together with an effervescent couple, such as citric acid - sodium bicarbonate. The combination of effervescence and chewability with optional flavourings improves the taste characteristics of the medicament in oral adminstration. A disintegrant such as microcrystalline cellulose may be added to give the patient the option of dispersing the tablet in water.

Drugs covered by this patent

Patent Metadata

Patent number
GB8909793D0
Jurisdiction
GB
Classification
—
Expires
1989-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Beecham Group PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.